Sang Hyeon Kang

Pharmacokinetics and Tolerance of the Phage Endolysin-Based Candidate Drug SAL200 after a Single Intravenous Administration among Healthy Volunteers

Soo Youn Jun, In Jin Jang, Seonghae Yoon et al. · Antimicrobial Agents and Chemotherapy · 2017 · 173 citations · Full text

Pharmacotherapy, Physiologically-based Pharmacokinetic Modeling, Drug Resistance +18

Antibacterial and biofilm removal activity of a podoviridae Staphylococcus aureus bacteriophage SAP-2 and a derived recombinant cell-wall-degrading enzyme

Jee Soo Son, Se-Jung Lee, Soo Youn Jun et al. · Applied Microbiology and Biotechnology · 2009 · 126 citations

Biofilms, Antimicrobial Susceptibility, Bacteriophage +6

Preclinical Safety Evaluation of Intravenously Administered SAL200 Containing the Recombinant Phage Endolysin SAL-1 as a Pharmaceutical Ingredient

Soo Youn Jun, Gi Mo Jung, Seong Jun Yoon et al. · Antimicrobial Agents and Chemotherapy · 2014 · 100 citations · Full text

Antibacterial properties of a pre-formulated recombinant phage endolysin, SAL-1

Soo Youn Jun, Gi Mo Jung, Seong Jun Yoon et al. · International Journal of Antimicrobial Agents · 2012 · 93 citations

Antibacterial Properties, Antibacterial Agent, Microbiology +4

Rapid activation of CLOCK by Ca ²⁺ ‐dependent protein kinase C mediates resetting of the mammalian circadian clock

Hong Seok Shim, Hyun Jung Kim, Ji‐Won Lee et al. · EMBO Reports · 2007 · 77 citations · Full text